Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine 2003 September;47(3) > The Quarterly Journal of Nuclear Medicine 2003 September;47(3):163-70

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

ORIGINAL ARTICLES  RADIOPHARMACOLOGY


The Quarterly Journal of Nuclear Medicine 2003 September;47(3):163-70

lingua: Inglese

Imaging the effects of anti-angiogenic treatments

Vavere A. L. 1,2, Lewis J. S. 2,3

1 Department of Chemistry Washington University School of Medicine, St. Louis, MO, USA
2 Division of Radiological Sciences, Washington University School of Medicine, St. Louis, MO, USA
3 Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA


FULL TEXT  


It is clear that various imaging modalities have given keen insight into the molecular mechanisms involved in anti-angiogenic treatments. A key to the advancement of anti-angiogenic therapy is not only the discovery of new drugs and treatments, but the analysis of the specific modes of action of these compounds in order to produce the next generation with greater effectiveness. While existing clinical methods incorporate the analysis of serum and urine to measure angiogenic factors, an imaging technique monitoring the effectiveness of anti-angiogenic therapy would be a convenient, noninvasive, cost effective technique to aid in treatment planning and disease management.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail